Sunil Healthcare profitability ratios

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY24Mar 2024
Returns
−2.4%
−1.1%
−1.9%
−1.1%
Margins
4.5%
−2.2%
−2.8%
−2.0%
−27.5%
Additional
−2.4%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

SUNLOC₹67.90

Sunil Healthcare Limited

· Pharma & Health
₹ CrorePeersBPLPHARMAJENBURPHKPLMAKERSLNOVARTINDPARNAXLABSGRLSHUKRAPHARMcap ₹69.8 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
Returns
Return on Common Equity-2.42
Return on Assets-1.09
Return on Capital Employed-1.87
Return on Invested Capital-1.07
Margins
EBITDA Margin4.53
Operating Margin-2.22
Pretax Margin-2.83
Net Income Margin-1.98
FCF Margin-27.51
Additional
Sustainable Growth Rate-2.42
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY24 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.